oncomed manufacturing

Executive Summary

Oncomed Manufacturing a.s., a Czech subsidiary of the German pharmaceutical company medac GmbH, specializes in the production of high-quality cytostatic injections for oncology patients. Established in 2008 and operational in Brno since 2010, the company plays a critical role in the supply chain for cancer treatments, leveraging medac's expertise in sterile manufacturing. As a private contract manufacturer, Oncomed is not a drug developer but a reliable producer of injectable chemotherapies, ensuring consistent quality and regulatory compliance. The company's strategic position within the medac group allows it to benefit from group-wide R&D and market access, while its facility in the Czech Republic offers cost advantages and proximity to European markets. With the oncology injectables market growing due to increasing cancer incidence and demand for generic cytotoxics, Oncomed is well-placed to expand its capacity and product portfolio, though specific financial and operational details remain limited due to its private status.

Upcoming Catalysts (preview)

• Q2 2027Expansion of manufacturing capacity or new production line60% success
• TBDNew product introduction from medac's pipeline40% success
• Q4 2026EU GMP certification renewal or upgrade90% success